Influence on brain perfusion and metabolism through pharmacologic agents
What it found
No result yet.
What it measured
Main measures
1) the difference in measures of cerebral perfusion before and after the use of trial medication in patients and controls
Who could take part
Progressive MS
Inclusion: 1) a diagnosis of multiple sclerosis according to the McDonald criteria with a secondary progressive disease course and a disease duration of between ten and fifteen years. Exclusion: 1) use of systemic corticosteroids in the eight weeks before the trial
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
In this trial we would like to investigate the influence of two pharmacologic interventions on brain perfusion and brain metabolism in patients with MS and in healthy control persons. Brain metabolism will be investigated with magnetic resonance spectroscopy and brain perfusion will be examined with contrast enhanced magnetic resonance imaging.
Loading reviews and guidelines…
History
Started
Aug 2006
Assembled by software from public sources and not checked by people. Each record links to its source. Report an error